Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2019

Open Access 01-12-2019 | Type 1 Diabetes | Research article

Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis

Authors: Xuemei Wang, Wei Shu, Jian Du, Maolin Du, Peiyu Wang, Mingming Xue, Huiqiu Zheng, Yufeng Jiang, Shaohua Yin, Danyan Liang, Ruiqi Wang, Lina Hou

Published in: BMC Endocrine Disorders | Issue 1/2019

Login to get access

Abstract

Background

As an insulin-dependent disease, type 1 diabetes requires paying close attention to the glycemic control. Studies have shown that mobile health (mHealth) can improve the management of chronic diseases. However, the effectiveness of mHealth in controlling the glycemic control remains uncertain. The objective of this study was to carry out a systematic review and meta-analysis using the available literature reporting findings on mHealth interventions, which may improve the management of type 1 diabetes.

Methods

We performed a systematic literature review of all studies in the PubMed, Web of Science, and EMbase databases that used mHealth (including mobile phones) in diabetes care and reported glycated hemoglobin (HbA1c) values as a measure of glycemic control. The fixed effects model was used for this meta-analysis.

Results

This study analyzed eight studies, which involved a total of 602 participants. In the meta-analysis, the fixed effects model showed a statistically significant decrease in the mean of HbA1c in the intervention group: − 0.25 (95% confidence interval: − 0.41, − 0.09; P = 0.003, I2 = 12%). Subgroup analyses indicated that the patient’s age, the type of intervention, and the duration of the intervention influenced blood glucose control. Funnel plots showed no publication bias.

Conclusions

Mobile health interventions may be effective among patients with type 1 diabetes. A significant reduction in HbA1c levels was associated with adult age, the use of a mobile application, and the long-term duration of the intervention.
Literature
1.
2.
Gale EAM. Type 1 diabetes in the young: the harvest of sorrow goes on. Diabetologia. 2005;48(8):1435–8.PubMedCrossRef
3.
Patterson CC, Gyürüs E, Rosenbauer J, Cinek O, Neu A, Schober E, Parslow RC, Joner G, Svensson J, Castell C. Trends in childhood type 1 diabetes incidence in Europe during 1989–2008: evidence of non-uniformity over time in rates of increase. Diabetologia. 2012;55(8):2142–7.CrossRef
4.
Giuseppina I, Boyle JP, Thompson TJ, Doug C, Dana D, Hamman RF, Lawrence JM, Liese AD, Liu LL, Mayer-Davis EJ: Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth. Diabetes Care 2012, 35(12):págs. 2515–2520.
5.
Gong C, Meng X, Jiang Y, Wang X, Cui H, Chen X. Trends in childhood type 1 diabetes mellitus incidence in Beijing from 1995 to 2010: A retrospective multicenter study based on hospitalization data. Diabetes Technol Ther. 2015;17(3):159-65.
6.
Rita Angélica GD, Nayely GN, Niels WR, Carlos Alberto AS. Epidemiology of type 1 diabetes in Latin America. Curr Diabetes Rev. 2014;10(2):75–85.CrossRef
7.
Herrath MGV, Korsgren O, Atkinson MA. Factors impeding the discovery of an intervention-based treatment for type 1 diabetes. Clin Exp Immunol. 2016;183(1):1-7.
8.
Nathan DM, Margaret B, Patricia C, Saul G, Rose GK, Lachin JM, Gayle L, Bernard Z. Diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions. Diabetes. 2013;62(12):3976–86.PubMedPubMedCentralCrossRef
9.
Cafazzo JA, Casselman M, Hamming N, Katzman DK, Palmert MR. Design of an mHealth app for the self-management of adolescent type 1 diabetes: A Pilot study. J Med Internet Res. 2012;14(3):e70.PubMedPubMedCentralCrossRef
10.
Munt R, Hutton A. Type 1 diabetes mellitus (T1DM) self management in hospital; is it possible? A literature review. Contemp Nurse. 2012;40(2):179–93.PubMedCrossRef
11.
Deacon AJ, Edirippulige S. Using mobile technology to motivate adolescents with type 1 diabetes mellitus: A systematic review of recent literature. J Telemed Telecare. 2015;21(8):431.PubMedCrossRef
12.
Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC. Telecare for patients with type 1 diabetes and inadequate glycemic control: a randomized controlled trial and meta-analysis. Diabetes Care. 2004;27(5):1088.PubMedCrossRef
13.
Balkhi AM, Reid AM, Westen SC, Olsen B, Janicke DM, Geffken GR. Telehealth interventions to reduce management complications in type 1 diabetes:A review. World J Diabetes. 2015;6(3):371–9.PubMedPubMedCentralCrossRef
14.
Lenhart A. Teens, Social Media & Technology Overview 2015; 2015.
15.
Edmonds M, Bauer M, Osborn S, Lutfiyya H, Mahon J, Doig G, Grundy P, Gittens C, Molenkamp G, Fenlon D. Using the vista 350 telephone to communicate the results of home monitoring of diabetes mellitus to a central database and to provide feedback. Int J Med Inform. 1998;51(2–3):117–25.PubMedCrossRef
16.
Piette JD, Weinberger M, Mcphee SJ, Mah CA, Kraemer FB, Crapo LM. Do automated calls with nurse follow-up improve self-care and glycemic control among vulnerable patients with diabetes? Am J Med. 2000;108(1):20–7.PubMedCrossRef
17.
Costa BM, Fitzgerald KJ, Jones KM, Trisha Dunning AM: Effectiveness of IT-based diabetes management interventions: a review of the literature. BMC Fam Pract 2009, 10(4):72–72.
18.
Biermann E, Dietrich W, Rihl J, Standl E. Are there time and cost savings by using telemanagement for patients on intensified insulin therapy? A randomised, controlled trial. Comput Methods Programs Biomed. 2002;69(2):137–46.CrossRef
19.
Courtney Rees L, Harris LT, Tung L, Jan F, James T, Diane B, James H, Hirsch IB, Goldberg HI, Ralston JD. Qualitative evaluation of a Mobile phone and web-based collaborative care intervention for patients with type 2 diabetes. Diabetes Technol Ther. 2011;13(5):563–9.CrossRef
20.
S L, SM K, H S, HJ L, J WY, SH Y, SY K, SY Y, HS J, KS P, et al. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care. 2011;34(2):308–13.CrossRef
21.
Huang Z, Tao H, Meng Q, Jing L. Management of endocrine disease. Effects of telecare intervention on glycemic control in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Eur J Endocrinol. 2015;172(3):R93–101.PubMedCrossRef
22.
Mohsen S, Ghader G, Koenig HG. Health education via mobile text messaging for glycemic control in adults with type 2 diabetes: a systematic review and meta-analysis. Primary Care Diabetes. 2014;8(4):275–85.CrossRef
23.
Toma T, Athanasiou T, Harling L, Darzi A, Ashrafian H. Online social networking services in the management of patients with diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. Diabetes Res Clin Prac. 2014;106(2):200–11.CrossRef
24.
Morwenna K, Corneel V, Andrew F, Duncan MJ. Diabetes self-management smartphone application for adults with type 1 diabetes: Randomized controlled trial. J Med Internet Res. 2013;15(11):197–204.
25.
Berndt RD, Takenga C, Preik P, Kuehn S, Berndt L, Mayer H, Kaps A, Schiel R. Impact of information technology on the therapy of type-1 diabetes: a case study of children and adolescents in Germany. J Personalized Med. 2014;4(2):200–17.CrossRef
26.
Yi H, Faulkner MS, Fritz H, Fadoju D, Muir A, Abowd GD, Head L, Arriaga RI, Pilot Randomized A. Trial of text-messaging for symptom awareness and diabetes knowledge in adolescents with type 1 diabetes. J Pediatr Nurs. 2015;30(6):850–61.CrossRef
27.
Inada M, Oishi M, Nishikawa M, Kurata S, Imura H. Clinical evaluation of measuring glycosylated hemoglobin levels for assessing the long-term blood glucose control in diabetics. Endocrinologia Japonica. 1980;27(4):411–5.PubMedCrossRef
28.
Higgins Jpt GS. Cochrane handbook for systematic reviews of interventions version 510. Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie. 2011;5(2):S38.
29.
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339(10):e1–e34.
30.
Hanauer DA, Wentzell K, Laffel N, Laffel LM. Computerized automated reminder diabetes system (CARDS): e-mail and SMS cell phone text messaging reminders to support diabetes management. Diabetes Technol Ther. 2009;11(2):99–106.PubMedPubMedCentralCrossRef
31.
Charpentier G, Benhamou PY, Dardari D, Clergeot A, Franc S, Schaepelynck-Belicar P, Catargi B, Melki V, Chaillous L, Farret A. The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 study). Diabetes Care. 2011;34(3):533–9.PubMedPubMedCentralCrossRef
32.
Rossi MCE, Nicolucci A, Bartolo PD, Bruttomesso D, Girelli A, Ampudia FJ, Kerr D, Ceriello A, Mayor CDLQ, Pellegrini F. Diabetes interactive diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study. Diabetes care. 2010;33(1):109–15.PubMedCrossRef
33.
Maria Chiara R, Antonio N, Giuseppe L, Fabio P, Paolo DB, Valerio M, Roberto A, Giacomo V. Impact of the “diabetes interactive diary” telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: A Randomized clinical trial in type 1 diabetes. Diabetes Technol Ther. 2013;15(8):670–9.CrossRef
34.
Franklin VL, Waller A, ., Pagliari C, ., Greene SA: A randomized controlled trial of sweet talk, a text-messaging system to support young people with diabetes. Diabet Med 2006, 23(12):1332–1338.PubMedCrossRef
35.
Winocour PH. Care of adolescents and young adults with diabetes - much more than transitional care: a personal view. Clin Med. 2014;14(3):274–8.CrossRef
36.
Fischer HH, Moore SL, Ginosar D, Davidson AJ, Rice-Peterson CM, Durfee MJ, Mackenzie TD, Estacio RO, Steele AW. Care by cell phone: text messaging for chronic disease management. Am J Manag Care. 2012;18(2):e42–7.PubMed
37.
Huang JS, Laura T, Trevor T, Lindsay D, Mark P, Michael G, Norman GJ, L Kay B. Preparing adolescents with chronic disease for transition to adult care: a technology program. Pediatrics. 2014;133(6):e1639–46.PubMedPubMedCentralCrossRef
38.
Fischer MA, Jones JB, Wright E, Van Loan RP, Xie J, Gallagher L, Wurst AM, Shrank WH. A Randomized telephone intervention trial to reduce primary medication nonadherence. J Managed Care Specialty Pharmacy. 2015;21(2):124–31.CrossRef
39.
Guo J, Whittemore R, Grey M, Wang J, Zhou ZG, He GP. Diabetes self-management, depressive symptoms, quality of life and metabolic control in youth with type 1 diabetes in China. J Clin Nurs. 2012;22(1–2):69–79.PubMed
40.
Skrøvseth SO, E Å, Godtliebsen F, Joakimsen RM. Data-driven personalized feedback to patients with type 1 diabetes: A Randomized trial. Diabetes Technol Ther. 2015;17(7).
41.
Herbert L, Owen V, Pascarella L, Streisand R. Text message interventions for children and adolescents with type 1 diabetes: A systematic review. Diabetes Technol Ther. 2013;15(5):362–70.PubMedCrossRef
42.
Harris MA, Hood KK, Mulvaney SA. Pumpers, Skypers, surfers and texters: technology to improve the management of diabetes in teenagers. Diabetes Obes Metab. 2012;14(11):967–72.PubMedCrossRef
43.
Borus JS, Lori L. Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention. Curr Opin Pediatr. 2010;22(4):405–11.PubMedPubMedCentralCrossRef
44.
Rausch JR, Hood KK, Alan D, Jennifer SP, Rohan JM, Grafton R, Lawrence D, Dennis D: Changes in treatment adherence and glycemic control during the transition to adolescence in type 1 diabetes. Diabetes Care 2012, 35(6):págs. 1219–1224.
45.
Greening L, Stoppelbein L, Konishi C, Jordan SS, Moll G. Child routines and youths' adherence to treatment for type 1 diabetes. J Pediatr Psychol. 2007;32(4):437–47.PubMedCrossRef
46.
Tasker AP, Gibson L, Franklin V, Gregor P, Greene S. What is the frequency of symptomatic mild hypoglycemia in type 1 diabetes in the young?: assessment by novel mobile phone technology and computer-based interviewing. Pediatr Diabetes. 2007;8(1):15–20.PubMedCrossRef
47.
Déglise C, Suggs LS, Odermatt P. SMS for disease control in developing countries: a systematic review of mobile health applications. J Telemedicine Telecare. 2012;18(5):273–81.CrossRef
48.
Brzan PP, Rotman E, Pajnkihar M, Klanjsek P. Mobile applications for control and self Management of Diabetes: A systematic review. J Med Syst. 2016;40(9):1–10.CrossRef
49.
Goyal S, ., Cafazzo JA: Mobile phone health apps for diabetes management: current evidence and future developments. Qjm Monthly Journal of the Association of Physicians 2013, 106(12):1067–1069.PubMedPubMedCentralCrossRef
Metadata
Title
Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis
Authors
Xuemei Wang
Wei Shu
Jian Du
Maolin Du
Peiyu Wang
Mingming Xue
Huiqiu Zheng
Yufeng Jiang
Shaohua Yin
Danyan Liang
Ruiqi Wang
Lina Hou
Publication date
01-12-2019
Publisher
BioMed Central
Keyword
Type 1 Diabetes
Published in
BMC Endocrine Disorders / Issue 1/2019
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-019-0347-6

Other articles of this Issue 1/2019

BMC Endocrine Disorders 1/2019 Go to the issue

Case report

Endocrine Manifestations in POEMS Syndrome: a case report and literature review

Case report

Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report

Research article

Impact of diabetes mellitus on functional exercise capacity and pulmonary functions in patients with diabetes and healthy persons

Research article

Poor short-term glycemic control in patients with type 2 diabetes impairs the intestinal mucosal barrier: a prospective, single-center, observational study

Research article

Endothelial cell-specific molecule-1 as an invasiveness marker for pituitary null cell adenoma

Research article

Serum zinc-α2-glycoprotein levels are elevated and correlated with thyroid hormone in newly diagnosed hyperthyroidism
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits